H2020HORIZON
Information Technology for Translational Medicine (Ittm) SA
- Country
- LULuxembourg
- Defence projects
- 0
- Projects, all programmes
- 15
- As coordinator
- 0
- EU contribution (CORDIS)
- EUR 10,083,286
- Active
- 2017 to 2025
Projects
15 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| READIResearch in Europe and Diversity Inclusion | HORIZON | 2025 | Participant | EUR 2,337,525 |
| EU-CIPEUropean Cancer Information Portal | HORIZON | 2025 | Participant | EUR 24,413 |
| SYNTHIASynthetic Data Generation Framework for Integrated Validation of Use Cases and AI Healthcare Applications | HORIZON | 2024 | Participant | EUR 432,500 |
| IDERHAIntegration of heterogeneous Data and Evidence towards Regulatory and HTA Acceptance | HORIZON | 2023 | Participant | EUR 882,500 |
| CERTAINTYA CEllulaR immunoTherapy virtuAl twin for personalIsed cancer treatmeNT | HORIZON | 2023 | Participant | EUR 632,384 |
| OPTIMAOptimal treatment for patients with solid tumours in Europe through Artificial intelligence | H2020 | 2021 | Participant | EUR 787,500 |
| ICU4CovidCyber-Physical Intensive Care Medical System for Covid-19 | H2020 | 2021 | Participant | EUR 168,888 |
| T2EVOLVEAccelerating Development and Improving Access to CAR and TCR-engineered T cell therapy | H2020 | 2021 | Participant | EUR 312,500 |
| ImmUniverseBetter control and treatment of immune-mediated diseases by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsies | H2020 | 2020 | Participant | EUR 400,501 |
| EU-PEARLEU Patient- cEntric clinicAl tRial pLatform | H2020 | 2019 | Participant | EUR 184,970 |
| Smart4HealthCitizen-centred EU-EHR exchange for personalised health | H2020 | 2019 | Participant | EUR 2,250,000 |
| TransBioLineTranslational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease | H2020 | 2019 | Participant | EUR 624,125 |
| BIOMAPBiomarkers in Atopic Dermatitis and Psoriasis | H2020 | 2019 | Participant | EUR 460,360 |
| imSAVARImmune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies | H2020 | 2019 | Participant | EUR 334,560 |
| GLIOTRAINExploiting GLIOblastoma intractability to address European research TRAINing needs in translational brain tumour research, cancer systems medicine and integrative multi-omics | H2020 | 2017 | Participant | EUR 250,560 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.